Doryx Antitrust Class Cert. Bids Fall Short, Warner Says
An antitrust lawsuit accusing Warner Chilcott PLC of attempting to stymie a generic version of the acne medication Doryx "falls woefully short" of the requirements for class action certification, the company...To view the full article, register now.
Already a subscriber? Click here to view full article